Chemed (CHE) Operating Expenses (2009 - 2026)

Chemed's Operating Expenses history runs 18 years deep, the most recent figure standing at $572.9 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 3.76% year-over-year to $572.9 million; the TTM figure through Mar 2026 stood at $2.2 billion (up 5.35% YoY), while the FY2025 annual figure was $2.2 billion, up 6.15% from the prior year.
• Operating Expenses was $572.9 million for Q1 2026 at Chemed, up from $538.7 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $572.9 million in Q1 2026 to a low of $439.4 million in Q2 2022.
• Historically, Operating Expenses has averaged $502.6 million across 5 years, with a median of $507.8 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses dropped 4.6% in 2022, then advanced 10.87% in 2024.
• A 5-year view of Operating Expenses shows it stood at $465.3 million in 2022, then advanced by 1.98% to $474.5 million in 2023, then grew by 10.87% to $526.1 million in 2024, then increased by 2.39% to $538.7 million in 2025, then gained by 6.36% to $572.9 million in 2026.
• The last three Operating Expenses figures came in at $572.9 million (Q1 2026), $538.7 million (Q4 2025), and $550.2 million (Q3 2025), per Business Quant data.